EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Recruiting · NCT06115486 · Interventional (participants receive a specific treatment) · Lead sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
View the official record on ClinicalTrials.gov →Interventions studied
Control Arm ACSM GuidelinesExperimental Arm 6-12-25 repetitions per set
What this trial is about
The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.
Who can take part
Age range
20 Years to 89 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age 20-89 years
- Women with a biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast
- Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Immunotherapy or targeted agent usage is allowed.
Exclusion criteria
- Any current treatment with cytotoxic chemotherapy for breast cancer
- Inability to safely engage in group sessions of resistance training as deemed by study PI
- Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training
Where it is running
1 location listed across 1 US state.
- Allegheny General Hospital - Pittsburgh, Pennsylvania, United States